Cadila healthcare launched an anti-obesity drug “Slimona” in India. The drug is used to treat obese patients with associated risk factors like type2 diabetes or dyslipidemia. Slimona (Rimonabant) is a selective CB1 Endocannabinoid (EC) receptor antagonist. The drug comes in a tablet form of strength 20 mg to be consumed before breakfast once a [...]
Recent Comments